source
- Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuriesBoston Scientific has issued another recall, this time for its spinal cord implant used to treat pain.Fierce Biotech · 9h ago↗ source
- Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durabilityInhibrx Biosciences’ CEO has argued that the 9.6 months of progression-free survival demonstrated by its OX40 agonist in a phase 2 study has proven the therapy’s durability in treating head and nec…Fierce Biotech · 17h ago↗ source
- Novo Nordisk abandons two phase 3 trials of ziltivekimab, dimming blockbuster hopesNovo Nordisk announced it is terminating two late‑stage phase 3 studies of its IL‑6 ligand antibody ziltivekimab. The Hermes and Athena trials enrolled about 4,900 and 673 patients with heart fail…